Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

Dear D.B.: This is a very touching story, and I hope to help readers understand a few points. Autosomal dominant polycystic ...

The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

November is National Diabetes Awareness Month and the American Diabetes Association is reporting that people with diabetes ...

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases ...

In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as compared with bisphosphonates among women with osteoporosis in the ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 ... kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with worsening CKD stage ...